Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Longerich

Showing results (191-200 of 227) with videos related to

Pageof 23
Sort By:
British Journal of Cancer|July 23, 2022
Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testingOlaf Neumann, Timothy C Burn, Michael Allgäuer, et al.
Cancer Cell|August 2, 2016
Dual Role of the Adaptive Immune System in Liver Injury and Hepatocellular Carcinoma DevelopmentJessica Endig, Laura Elisa Buitrago-Molina, Silke Marhenke, et al.
Nature|September 14, 2018
Necroptosis microenvironment directs lineage commitment in liver cancerMarco Seehawer, Florian Heinzmann, Luana D'Artista, et al.
JHEP Reports : Innovation in Hepatology|May 13, 2024
Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trialPhilipp Hoegen-Saßmannshausen, Patrick Naumann, Paula Hoffmeister-Wittmann, et al.
Cell Host & Microbe|January 18, 2011
Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartmentSimon Reiss, Ilka Rebhan, Perdita Backes, et al.
Nature|November 10, 2018
Author Correction: Necroptosis microenvironment directs lineage commitment in liver cancerMarco Seehawer, Florian Heinzmann, Luana D'Artista, et al.
Gut|March 16, 2019
Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitisLijun Liao, Kai Markus Schneider, Eric J C Galvez, et al.
Nature|November 15, 2011
Senescence surveillance of pre-malignant hepatocytes limits liver cancer developmentTae-Won Kang, Tetyana Yevsa, Norman Woller, et al.
JHEP Reports : Innovation in Hepatology|March 7, 2020
Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancerSven H Loosen, Annemarie Breuer, Frank Tacke, et al.
Hepatology Communications|September 24, 2021
Transcriptomic Cross-Species Analysis of Chronic Liver Disease Reveals Consistent Regulation Between Humans and MiceChristian H Holland, Ricardo O Ramirez Flores, Maiju Myllys, et al.
Pageof 23

Showing results (191-200 of 227) with videos related to

Sort By:
Pageof 23
British Journal of Cancer|July 23, 2022
Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testingOlaf Neumann, Timothy C Burn, Michael Allgäuer, et al.
Cancer Cell|August 2, 2016
Dual Role of the Adaptive Immune System in Liver Injury and Hepatocellular Carcinoma DevelopmentJessica Endig, Laura Elisa Buitrago-Molina, Silke Marhenke, et al.
Nature|September 14, 2018
Necroptosis microenvironment directs lineage commitment in liver cancerMarco Seehawer, Florian Heinzmann, Luana D'Artista, et al.
JHEP Reports : Innovation in Hepatology|May 13, 2024
Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trialPhilipp Hoegen-Saßmannshausen, Patrick Naumann, Paula Hoffmeister-Wittmann, et al.
Cell Host & Microbe|January 18, 2011
Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartmentSimon Reiss, Ilka Rebhan, Perdita Backes, et al.
Nature|November 10, 2018
Author Correction: Necroptosis microenvironment directs lineage commitment in liver cancerMarco Seehawer, Florian Heinzmann, Luana D'Artista, et al.
Gut|March 16, 2019
Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitisLijun Liao, Kai Markus Schneider, Eric J C Galvez, et al.
Nature|November 15, 2011
Senescence surveillance of pre-malignant hepatocytes limits liver cancer developmentTae-Won Kang, Tetyana Yevsa, Norman Woller, et al.
JHEP Reports : Innovation in Hepatology|March 7, 2020
Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancerSven H Loosen, Annemarie Breuer, Frank Tacke, et al.
Hepatology Communications|September 24, 2021
Transcriptomic Cross-Species Analysis of Chronic Liver Disease Reveals Consistent Regulation Between Humans and MiceChristian H Holland, Ricardo O Ramirez Flores, Maiju Myllys, et al.
Pageof 23